Company Filing History:

3 out of 130

Biogen, Incorporated

Years Active: 1986-2001

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6297355 - Polypeptides displaying HBV antigenicity or hbv antigen specificity (2001-10-02),

2. 6270955 - Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus (2001-08-07),

3. 6268122 - Recombinant DNA molecules and their method of production (2001-07-31),

4. 4758507 - Products displaying the antigenicity of hepatitis B virus e antigens and (1988-07-19),

5. 4710463 - Recombinant DNA molecules capable of expressing HBV core and surface (1987-12-01),

6. 4563423 - Products displaying the antigenicity of hepatitis B virus e antigens and (1986-01-07),

Title: Kenneth Murray: Innovator in Hepatitis B Research

Introduction

Kenneth Murray is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies related to hepatitis B virus (HBV).

Latest Patents

Kenneth Murray holds six patents, with his latest innovations focusing on polypeptides that display HBV antigenicity. His patents include recombinant DNA molecules and hosts transformed with them, which produce polypeptides displaying HBV antigenicity. These inventions are characterized by structural genes that code for at least one polypeptide displaying HBV antigenicity. In suitable hosts, these recombinant DNA molecules facilitate the production and identification of genes and polypeptides that are characteristic of HBV antigenicity. They are also utilized in methods for detecting HBV virus infections in humans and stimulating the production of antibodies against this infection.

Career Highlights

Throughout his career, Kenneth Murray has worked with notable companies in the biotechnology sector, including Biogen, Incorporated and Biogen N.V. His work has significantly advanced the understanding and treatment of hepatitis B virus infections.

Collaborations

Kenneth has collaborated with various professionals in his field, including Patricia MacKay, enhancing the impact of his research and innovations.

Conclusion

Kenneth Murray's contributions to biotechnology, particularly in the area of hepatitis B research, have been invaluable. His innovative patents and collaborations continue to influence the field and improve health outcomes related to HBV.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.